ストックスクリーナーアプリを入手
3.10
0.00%
0.00
前日終値:
$3.10
開ける：
$3.17
24時間の取引高:
19,341
Relative Volume:
0.18
時価総額：
$26.25M
収益：
$10.16M
当期純損益:
$-47.57M
株価収益率:
-0.3762
EPS:
-8.24
ネットキャッシュフロー:
$-42.73M
1週間 パフォーマンス:
-3.73%
1か月 パフォーマンス:
-9.62%
6か月 パフォーマンス:
-48.33%
1年 パフォーマンス:
-69.81%
1日の値動き範囲:
$3.07
$3.215
1週間の範囲:
$3.07
$3.4094
52週間の値動き範囲:
$2.86
$17.49
Curis Inc Stock (CRIS) Company Profile
CRIS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
3.10 | 26.25M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-17 | 開始されました | Truist | Buy |
| 2022-04-04 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | 開始されました | Raymond James | Outperform |
| 2021-03-25 | 開始されました | B. Riley Securities | Buy |
| 2020-07-29 | 開始されました | Laidlaw | Buy |
| 2020-07-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-10-24 | 開始されました | Guggenheim | Buy |
| 2016-03-02 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | 繰り返されました | ROTH Capital | Buy |
| 2015-08-11 | 開始されました | FBR Capital | Outperform |
| 2015-01-22 | 繰り返されました | Oppenheimer | Outperform |
| 2015-01-21 | 繰り返されました | ROTH Capital | Buy |
| 2014-05-09 | 繰り返されました | Oppenheimer | Outperform |
| 2013-10-02 | 開始されました | Robert W. Baird | Outperform |
| 2013-09-30 | 開始されました | Chardan Capital Markets | Buy |
| 2012-11-14 | 開始されました | Stifel Nicolaus | Hold |
| 2012-01-31 | 繰り返されました | Brean Murray | Buy |
| 2012-01-31 | 繰り返されました | Summer Street Research | Buy |
| 2011-12-09 | 開始されました | Oppenheimer | Outperform |
| 2011-10-06 | 開始されました | Summer Street Research | Buy |
| 2011-09-22 | 開始されました | MLV Capital | Buy |
| 2011-03-21 | 繰り返されました | Brean Murray | Buy |
| 2010-02-26 | 繰り返されました | Roth Capital | Buy |
| 2010-01-07 | 開始されました | Roth Capital | Buy |
すべてを表示
Curis Inc (CRIS) 最新ニュース
Curis (CRIS) Expected to Announce Quarterly Earnings on Thursday - Defense World
CURIS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
BostInnoHappy New Year! | Inno Approved Events - The Business Journals
Diddy, Jay-Z Rape Lawsuit Dropped Amid Legal Ethics Battle - Law360
CRISCuris Provides Second Quarter 2024 Financial and Operating Update - br.ADVFN.com
Curis (CRIS) Projected to Post Earnings on Thursday - Defense World
Jay-Z Sex Assault Suit Invalid Under Law, Rapper Says - Law360
Jay-Z Blasts Buzbee For 'Reputation-Destroying Allegations' - Law360
Investor Network: Curis, Inc. to Host Earnings Call - ACCESS Newswire
Curis, Inc. to Host Earnings Call - ACCESS Newswire
Cantor Fitzgerald Comments on Curis FY2025 Earnings - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Curis stock plunges to 52-week low, now at $3.0 By Investing.com - Investing.com Nigeria
Curis stock plunges to 52-week low, now at $3.0 - Investing.com
Curis, Inc.'s (NASDAQ:CRIS) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St
Critical Comparison: Curis (NASDAQ:CRIS) vs. Cyclo Therapeutics (NASDAQ:CYTH) - Defense World
Curis, Inc. (NASDAQ:CRIS) Short Interest Down 39.4% in December - Defense World
Curis Inc (CRIS) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 - The Eastern Progress Online
Curis stock plunges to 52-week low, hits $3.5 amid downturn By Investing.com - Investing.com South Africa
Curis stock plunges to 52-week low, hits $3.5 amid downturn - Investing.com Canada
Curis reports promising AML study results By Investing.com - Investing.com Canada
Curis, Inc. Announces Additional Data from Take Aim Leukemia Study - Marketscreener.com
Curis reports promising AML study results - Investing.com India
Curis Announces Additional Data from TakeAim Leukemia Study - PR Newswire
Curis (NASDAQ:CRIS) Shares Down 2.3% – Time to Sell? - Defense World
Curis (CRIS) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
Curis to Present at Upcoming Healthcare Conferences in September - The Eastern Progress Online
Curis Inc (CRIS) Stock Surges 5.46% Amid Positive Analyst Ratings - GuruFocus.com
Curis Announces $12.1 Million Registered Direct and Concurrent P - GuruFocus.com
Curis to Report Third Quarter 2024 Financial and Operating Resul - GuruFocus.com
Curis Provides Third Quarter 2024 Business Update - GuruFocus.com
Curis: Q3 Earnings Snapshot - Marketscreener.com
Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates - MSN
Curis’ (CRIS) Buy Rating Reiterated at HC Wainwright - Defense World
Curis Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Curis, Inc. (NASDAQ:CRIS) Q3 2024 Earnings Call Transcript - Insider Monkey
Curis Inc (CRIS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ... - Yahoo Finance
Curis Inc (CRIS) Q3 2024 Earnings Call Highlights: Navigating Fi - GuruFocus.com
Earnings call: Curis Reports Progress in Clinical Studies and Financials - Investing.com India
Curis Inc. Reports Positive Q3 2024 Earnings - TipRanks
Curis reports progress in clinical trials By Investing.com - Investing.com Australia
Curis Inc (CRIS) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):